| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.3 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.3 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.067 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.3 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |